Ven-PegC did not show any negative effect on organ function including asparaginase-related adverse events of special interest (i.e., elevated liver or pancreas enzymes, hyperbilirubinemia, coagulation tests and fibrinogen level) in immunocompromised and immunocompetent mice. The gene discussed is ASPG; the disease is Hyperbilirubinemia.